Convergence of CRISPR and Stem Cells is Changing Regenerative Medicine

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/97/48/6f/97486f51-a3a1-4892-bdd4-7b7dda89bf13/mza_5148514960926470534.jpg/600x600bb.jpg

Longevity for Investors with Dr. Greg Bailey and Jess Larsen

Graystoke Networks

18 episodes

9 months ago

The Longevity for Investors podcast mini-series is co-hosted by Dr. Greg Bailey, Chairman of Juvenescence https://www.drgregbailey.com/ and Jess Larsen. On this series we interview top Longevity experts, CEOs, as well as other interesting High Profile people.

All content for Longevity for Investors with Dr. Greg Bailey and Jess Larsen is the property of Graystoke Networks and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Investing

Business,

Health & Fitness

https://megaphone.imgix.net/podcasts/973114b0-7b8d-11ef-9af2-27b47acf402a/image/5af47f544663becc487aeb0546b3dab9.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress

Convergence of CRISPR and Stem Cells is Changing Regenerative Medicine | Cure8bio CEO, Faizzan Ahmad

Longevity for Investors with Dr. Greg Bailey and Jess Larsen

47 minutes

1 year ago

Convergence of CRISPR and Stem Cells is Changing Regenerative Medicine | Cure8bio CEO, Faizzan Ahmad

Join Dr. Faizzan Ahmad, CEO of Cure8bio, as he explores the frontier of regenerative medicine. From his journey at Oxford to pioneering a hub-and-spoke biotech model, Dr. Ahmad discusses the latest advancements in stem cell therapies, gene editing, and their potential to cure previously untreatable diseases. Learn how these innovations are reshaping the future of healthcare and longevity.